Eyenovia to Present at Two Upcoming Investor Conferences

NEW YORK, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print delivery technology, today announced that Dr. Sean Ianchulev, Eyenovia’s Chief Executive Officer and Chief Medical Officer and John Gandolfo, Eyenovia’s Chief Financial Officer, are scheduled to present at the 21st Annual H.C. Wainwright 21st Annual Global Investment Conference being held on September 8-10, 2019 and the Ladenburg Thalmann 2019 Healthcare Conference being held on September 24, 2019 in New York.

Details for the presentations are below:

Event: H.C. Wainwright 21st Annual Global Investment ConferenceDate: Tuesday, September 10, 2019Time: 5:05 – 5:30pm ETLocation: Lotte New York Palace HotelRoom: Kennedy I (4th Floor)

Event: Ladenburg Thalmann 2019 Healthcare ConferenceDate: Tuesday, September 24, 2019Time: 2:00 – 2:25pm ETLocation: Sofitel New YorkRoom: Track 5 - Montmartre

A live webcast of the Company’s presentation at the H.C. Wainwright 21st Annual Global Investment Conference may be accessed on the Company's website at www.eyenovia.com. The webcast will be archived for 90 days following the live presentation on the Company's website.

Eyenovia’s management team will also be available for one-on-one meetings with investors who are registered to attend the events. Alternatively, interested investors may contact Tram Bui of The Ruth Group at [email protected] or (646) 536-7035 to schedule a meeting.

About EyenoviaEyenovia, Inc. (NASDAQ: EYEN) is a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patent piezo-print delivery technology. Eyenovia’s pipeline is currently focused on the late-stage development of microdosed medications for mydriasis, myopia progression, glaucoma and other eye diseases. For more information please visit www.eyenovia.com.

Company Contact:Eyenovia, Inc.John GandolfoChief Financial Officer[email protected]

Investor Contact:Tram Bui / Alexander LoboThe Ruth GroupPhone: 646-536-7035/7037[email protected] / [email protected]

Media Contact:The Ruth GroupKirsten Thomas508-280-6592[email protected]

You May Also Be Interested In

• Breeze Acquisition Corp. II Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Reports on Form 10-Q
• ESS Tech, Inc. Announces Closing of $3.2 Million Registered Direct Offering and Concurrent Private Placement
• Rent the Runway to Report Second Quarter 2026 Results on September 11, 2026